Tauvid Injection, Solution
Product Images NDC 0002-1220

This is a description of Tauvid™, which is a radioactive injection that contains flortaucipir F 18. The injection comes in a 50 mL multiple-dose vial and is a prescription-only medication. It contains up to 2 micrograms of flortaucipir, 1.5 mg of L-cysteine hydrochloride monohydrate USP, 2.1 mg of dibasic sodium phosphate anhydrous USP, up to 55 micrograms of hydrogen chloride and 0.1 mL dehydrated alcohol USP in 0.9% sodium chloride injection USP per milliliter of solution. The injection is manufactured by PETNET Solutions, Inc. Knoxville, TN 37932 for Avid Radiopharmaceuticals, a wholly-owned subsidiary of Eli Lilly and Company, Philadelphia, PA 19104. The vial should be stored upright in a shielding container at 25°C (77°F), with permitted temperature excursions to 15°C to 30°C (59°F to 86°F).*

This is a description of a medication named Tauvid. It comes in a multiple-dose vial of 50 mL and contains Flortaucipir F 18 Injection, which is a radioactive material. It has a radioactivity range of 300 MBg/mL to 1,900 MBg/mL (8.1 mCi/mL to 51 mCi/mL) at the end of synthesis. The medication expires on a certain date and has a batch number. It should be stored upright in a shielding container between 15°C to 30°C (59°F to 86°F). The manufacturer is PETNET Solutions, Inc. and it is produced for Avid Radiopharmaceuticals, which is a subsidiary of Eli Lilly and Company. The text also mentions that the medication contains up to 2 micrograms of flortaucipir and 0.1 mL dehydrated alcohol USP in 0.9% sodium chloride injection USP per milliliter of solution.*